CS Bio
Chemicals & Related Products · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
20 Kelly Ct, Menlo Park, California, 940...Phone Number
(650) 322-1111Website
www.csbio.comRevenue
$97.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About CS Bio
CSBio is a leading peptide synthesis instrumentation company based in Silicon Valley, California, specializing in automated peptide and DNA synthesizers. Since its inception in 1993, the company has served the global pharmaceutical community, with its products utilized in over 30 countries across various sectors including universities, research institutes, and biotech firms. CSBio offers a range of synthesizers from research to commercial scale, with many systems custom built to meet specific client needs. With over 30 years of experience, CSBio is recognized for its innovative and reliable synthesis equipment.Explore more
CS Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CS Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if CS Bio has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on CS Bio recently announced quarterly report
Check out if CS Bio is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at CS Bio
Click to see if CS Bio had a recent Job posting/layoffs
Funding: Get notified immidiatlly once CS Bio has new funding data
CS Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when CS Bio launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to CS Bio
Compare insights from companies similar to CS Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CS Bio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CS Bio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CS Bio.
CS Bio financials insights
Gather financial insights about CS Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$1M
2021
Debt
$1.5M
CS Bio Tech Stack
A closer look at the technologies used by CS Bio
Most Recent Scoops
Open Position
Open Position
Hiring Plans
CS Bio has more open roles in Engineering & Technical than it has had at any time in the past 12 months. Areas of expertise include: Software Engineering, JSON, Data Structures, Streamlit, Data Architecture, Integral Calculus, and Data Science.
Hiring Plans
Open Position
Open Position
CS Bio News & Media
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CS Bio
Sign Up For FreeTo access detailed company insights
CSBio is a leading peptide synthesis instrumentation company based in Silicon Valley, California, specializing in automated peptide and DNA synthesizers. Since its inception in 1993, the company has served the global pharmaceutical community, with its products utilized in over 30 countries across various sectors including universities, research ins... Read More
